简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Quantum Bizerma重新获得纳斯达克合规性

2024-09-09 13:35

  • Quantum BioPharma (NASDAQ:QNTMreceived Nasdaq notice stating that the company has regained compliance with the minimum bid price requirement.
  • The company is now in compliance with all applicable listing standards and will continue to be listed and traded on the Nasdaq.
  • In addition, the company has completed debt settlements in the amount of $450K with each of Anthony Durkacz, Zeeshan Saeed and Donal Carroll, officers of the company. 

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。